ATE213934T1 - Arzneimittel auf basis von progesteron und östradiol - Google Patents

Arzneimittel auf basis von progesteron und östradiol

Info

Publication number
ATE213934T1
ATE213934T1 AT97919485T AT97919485T ATE213934T1 AT E213934 T1 ATE213934 T1 AT E213934T1 AT 97919485 T AT97919485 T AT 97919485T AT 97919485 T AT97919485 T AT 97919485T AT E213934 T1 ATE213934 T1 AT E213934T1
Authority
AT
Austria
Prior art keywords
pct
oil
estradiol
progesterone
dissolve
Prior art date
Application number
AT97919485T
Other languages
English (en)
Inventor
Dominique Salin-Drouin
Original Assignee
Besins Iscovesco Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Iscovesco Sa Lab filed Critical Besins Iscovesco Sa Lab
Application granted granted Critical
Publication of ATE213934T1 publication Critical patent/ATE213934T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
AT97919485T 1996-04-05 1997-04-04 Arzneimittel auf basis von progesteron und östradiol ATE213934T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604349A FR2747042B1 (fr) 1996-04-05 1996-04-05 Medicament a base de progesterone et d'oestradiol
PCT/FR1997/000612 WO1997037642A1 (fr) 1996-04-05 1997-04-04 Medicament a base de progesterone et d'oestradiol

Publications (1)

Publication Number Publication Date
ATE213934T1 true ATE213934T1 (de) 2002-03-15

Family

ID=9490985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919485T ATE213934T1 (de) 1996-04-05 1997-04-04 Arzneimittel auf basis von progesteron und östradiol

Country Status (9)

Country Link
US (1) US6077531A (de)
EP (1) EP0896529B1 (de)
JP (1) JP2000508309A (de)
AT (1) ATE213934T1 (de)
CA (1) CA2251002C (de)
DE (1) DE69710879T2 (de)
ES (1) ES2172782T3 (de)
FR (1) FR2747042B1 (de)
WO (1) WO1997037642A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
US20060052341A1 (en) 2002-02-08 2006-03-09 Brian Cornish Control of a biological function
CA2528545C (en) 2003-06-13 2014-08-12 John Claude Savoir Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
WO2005035717A2 (en) 2003-10-03 2005-04-21 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
RU2568839C2 (ru) 2009-04-23 2015-11-20 ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК Способ и композиция для синхронизации времени осеменения
WO2011073995A2 (en) 2009-12-14 2011-06-23 Lincoln Pharmaceuticals Limited Liquid vaginal spray of progesterone
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
EP2925339B1 (de) 2012-11-28 2020-04-29 United-AH II, LLC Verfahren zur synchronisierung der befruchtungszeit bei jungsauen
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (de) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und therapien
RU2016141135A (ru) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. Трансдермальный крем
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
JPH08511559A (ja) * 1993-06-18 1996-12-03 スミスクライン・ビーチャム・コーポレイション 軟外皮ゼラチンに封入された粒子

Also Published As

Publication number Publication date
ES2172782T3 (es) 2002-10-01
FR2747042A1 (fr) 1997-10-10
CA2251002C (fr) 2007-01-30
EP0896529B1 (de) 2002-03-06
DE69710879T2 (de) 2002-11-14
WO1997037642A1 (fr) 1997-10-16
JP2000508309A (ja) 2000-07-04
FR2747042B1 (fr) 1998-06-05
EP0896529A1 (de) 1999-02-17
US6077531A (en) 2000-06-20
DE69710879D1 (de) 2002-04-11
CA2251002A1 (fr) 1997-10-16

Similar Documents

Publication Publication Date Title
ATE213934T1 (de) Arzneimittel auf basis von progesteron und östradiol
ATE126429T1 (de) Zusammensetzung auf der basis von silikon und latex zur behandlung von keratinösen substanzen.
DE19581906T1 (de) Lokale Abgabe bzw. Zuführung und Überwachung von Arzneimitteln
DE59604603D1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
DE69305328D1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
DE59608732D1 (de) Lagerstabile arzneiformen
FR2794466B1 (fr) Composition sous forme d'emulsion huile-dans-eau contenant des fibrilles de cellulose et ses utilisations notamment cosmetiques
DE69228997D1 (de) Menschliche il-3-varianten
DK0706385T3 (da) Anvendelse af isovaleramid som et mildt anxiolytisk og et mildt sedativt middel
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
DE59100496D1 (de) Verwendung von selektiv hydrierten Styrol-Butadien-Copolymerisaten in kosmetischen und pharmazeutischen Zubereitungen.
DE69328193D1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
FR2688135B1 (fr) Composition cosmetique pour le maintien de la coiffure, contenant un proteine de lait et/ou un hydrolysat de proteine de lait et un hydrolysat de keratine.
DZ2564A1 (fr) Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
DE69616591D1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
Willcox Health scare
BR9611619B1 (pt) ciclopeptolìdeos e composição farmacêutica que os contêm.
DK0825859T3 (da) Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed
DE69634536D1 (de) 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties